Alan B. Lancz & Associates, Inc. Senseonics Holdings, Inc. Transaction History
Alan B. Lancz & Associates, Inc.
- $98.1 Million
- Q2 2025
A detailed history of Alan B. Lancz & Associates, Inc. transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Alan B. Lancz & Associates, Inc. holds 34,500 shares of SENS stock, worth $15,180. This represents 0.02% of its overall portfolio holdings.
Number of Shares
34,500
Previous 34,500
-0.0%
Holding current value
$15,180
Previous $22,000
27.27%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding SENS
# of Institutions
157Shares Held
145MCall Options Held
588KPut Options Held
299K-
First Light Asset Management, LLC Edina, MN35.7MShares$15.7 Million2.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA33.5MShares$14.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA8.7MShares$3.83 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.32MShares$3.66 Million0.0% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL7.92MShares$3.49 Million0.06% of portfolio
About Senseonics Holdings, Inc.
- Ticker SENS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 465,447,008
- Market Cap $205M
- Description
- Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...